Form 13-F position report

INVO BIOSCIENCE INC

Reported by IEQ CAPITAL LLC

INVO CUSIP 44984F302 Manager CIK 0001779789

Reported 0 shares, down 50,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-09-30 53000
2022-12-31 21190
2023-03-31 31950
2023-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for INVO BIOSCIENCE INC held by IEQ CAPITAL LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2023 Reduced 0 -50,000 (-100.0%) 0 $0 2023-08-08
Q1 2023 Unchanged 50,000 0 (0.0%) < 0.01% $31,950 2023-05-02
Q4 2022 Unchanged 50,000 0 (0.0%) < 0.01% $21,190 2023-02-06
Q3 2022 New 50,000 +50,000 (0.0%) < 0.01% $53,000 2022-11-04

Who else reported the position

26 managers reported INVO BIOSCIENCE INC for Q2 2023.

Managers reporting INVO BIOSCIENCE INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
AWM Investment Company Inc Unchanged 623,860 0 0.02% $127,267 11 qtrs
VANGUARD GROUP INC Reduced 105,539 -2,729 < 0.01% $21,129 10 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 87,194 0 < 0.01% $17,787 10 qtrs
TWO SIGMA SECURITIES LLC New 28,551 +28,551 < 0.01% $5,716 1 qtr
Virtu Financial LLC Added 24,051 +2,505 < 0.01% $5,000 2 qtrs
STATE STREET CORPORATION Unchanged 23,781 0 < 0.01% $4,851 9 qtrs
RENAISSANCE TECHNOLOGIES LLC New 20,200 +20,200 < 0.01% $4,000 1 qtr
ADVISOR GROUP HOLDINGS INC Unchanged 12,181 0 < 0.01% $2,439 11 qtrs
NORTHERN TRUST CORPORATION Unchanged 11,408 0 < 0.01% $2,284 10 qtrs
ROYAL BANK OF CANADA Unchanged 10,773 0 < 0.01% $2,000 11 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 08, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.